ISSN: 2574-187X
Authors: Shewale S, Shewale S, Bachhav R*, Bachhav P, Pansare L and Sonawane G
By reducing collateral toxicity to nonmalignant cells, nanotechnology has the potential to improve the efficacy and selectivity of chemical, physical, and biological methods for inducing cancer cell death. More and more materials at the nanoscale are being actively and passively targeted to specifically target cancer cells. This review focuses on how different tactics with distinct identifying qualities set nanoparticles apart from earlier anticancer medicines in terms of their capacity to recognize cells. Additionally, it talks about how precise medication delivery via nanoparticles inside the cells has been the subject of numerous successful studies, as well as how nanoparticles can be used to treat cancer specifically while removing the side effects of conventional medicines.
Keywords: Nano Medicine; Cancer; Nano Technology
